Aileron Goes After Cancer’s Hard Target, P53, With Peptide Drug – Xconomy

See on Scoop.itBioTechnology

Aileron Goes After Cancer’s Hard Target, P53, With Peptide Drug
Xconomy
P53 is bound to the DNA in the nucleus, and has been named as the “Guardian of the Genome,” because it is the cell’s first line of defense.

See on www.xconomy.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: